Zhende Medical Co., Ltd. (603301.SS) SHH

Currency In CNY

AD

Valuation

Market Cap18.57B
Enterprise Value19.09B
P/E Ratio75.93
PEG Ratio-3.48
Price/Sales Ratio4.68
Price/Book Ratio3.67
Enterprise/Revenue4.82
Enterprise/EBITDA34.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.06
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue4.33B
Revenue/Share16.88
Gross Profit1.47B
EBITDA653.7M
Net Income260.82M
Diluted EPS0.99

Balance Sheet

Total Cash960.74M
Total Cash/Share3.64
Total Debt1.33B
Total Debt/Equity0.23
Current Ratio1.66
Book Value Per Share22.51

Price History

52-Week Change11.37
52-Week High104.84
52-Week Low62.14
Moving Average 50 Days80.3
Moving Average 200 Days84.88

Statistics

Average Volume1.61M
Shares Outstanding263.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield0.38
Payout Ratio0.39
Last Split Factor7:5
Last Split DateJune 08, 2020
AD